GRUR international最新文献

Infringement of European and National Utility Model Patents 侵犯欧洲和国家实用新型专利权

GRUR international Pub Date : 2024-08-09 DOI: 10.1093/grurint/ikae105

引用次数: 0

Public Order as a Ground for Revoking Trademark Registration 以公共秩序为由撤销商标注册

GRUR international Pub Date : 2024-08-08 DOI: 10.1093/grurint/ikae101

引用次数: 0

Determining the Potential to Impair the Distinctiveness of a Well-Known Trademark 确定损害驰名商标显著性的可能性

GRUR international Pub Date : 2024-07-26 DOI: 10.1093/grurint/ikae098

引用次数: 0

Whether Refilling and Relabelling Goods Create a False Impression of an Economic Connection 重新灌装和重新贴标签是否造成经济联系的假象

GRUR international Pub Date : 2024-07-26 DOI: 10.1093/grurint/ikae099

引用次数: 0

Correction to: Use of Trade Mark in the Title of a Book 更正：在书名中使用商标

GRUR international Pub Date : 2024-07-24 DOI: 10.1093/grurint/ikae104

引用次数: 0

Revisiting G 1/19 Three Years Later: A Missed Opportunity? 三年后重温 G 1/19：错失良机？

GRUR international Pub Date : 2024-07-20 DOI: 10.1093/grurint/ikae090

Michael M Fischer

引用次数: 0

New Progress in China’s Anti-Monopoly Investigation into the Pharmaceutical Industry – Comment on the Injectable Polymyxin B Sulfate Case 中国医药行业反垄断调查新进展--评注射用硫酸多粘菌素B案

GRUR international Pub Date : 2024-07-20 DOI: 10.1093/grurint/ikae091

De Wei

引用次数: 0

Playing Regulatory Catch-up? – The Relevance of EDPB Guidelines 2/2023 on the Technical Scope of Art. 5(3) of the ePrivacy Directive 在监管方面迎头赶上？- 关于《电子隐私指令》第 5(3)条技术范围的 EDPB 准则 2/2023 的相关性电子隐私指令》第 5(3)条的相关性

GRUR international Pub Date : 2024-07-19 DOI: 10.1093/grurint/ikae095

Florian Idelberger

{"title":"Playing Regulatory Catch-up? – The Relevance of EDPB Guidelines 2/2023 on the Technical Scope of Art. 5(3) of the ePrivacy Directive","authors":"Florian Idelberger","doi":"10.1093/grurint/ikae095","DOIUrl":"https://doi.org/10.1093/grurint/ikae095","url":null,"abstract":"\u0000 Recently, the European Data Protection Board (the EDPB) released new guidelines on the technical scope of Art. 5(3) of the ePrivacy Directive (the ePD) and held its consultation procedure. These guidelines aim to clarify the scope and details of Art. 5(3), specifically what ‘the storing of information, or to gain access to information stored in the terminal equipment of a subscriber or user’ means on a technical level. This opinion describes the circumstances under which such information may be stored or accessed.\u0000 In this contribution I pose the hypothesis that the broadening of the published guidelines is at least in part necessary to prevent the ePD from becoming irrelevant, if only non-covered techniques are to be used. In this opinion, I will first discuss the background of the ePD, provide context for the guidelines and their structure, and then follow and comment on the respective parts of the analysed phrase alongside the analysis of the EDPB. In the end, I will conclude and check if all the latest developments are likely to be caught by the new interpretation according to the technical guidelines, and what this could mean for legal practice.","PeriodicalId":487734,"journal":{"name":"GRUR international","volume":"111 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141821126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Regulatory Governance Perspective on IP and Access to Medicines – A Fresh Look Into the TRIPS Agreement 从监管治理角度看知识产权与药品获取--重新审视《与贸易有关的知识产权协议

GRUR international Pub Date : 2024-07-19 DOI: 10.1093/grurint/ikae092

Gustavo Ghidini, Riccardo Piselli

{"title":"A Regulatory Governance Perspective on IP and Access to Medicines – A Fresh Look Into the TRIPS Agreement","authors":"Gustavo Ghidini, Riccardo Piselli","doi":"10.1093/grurint/ikae092","DOIUrl":"https://doi.org/10.1093/grurint/ikae092","url":null,"abstract":"\u0000 As concerns the relationship between the Global South and the developed countries, the TRIPS Agreement provides a robust protection of IP. This might result in a weaker protection of fundamental rights, such as health, in those countries that do not possess the necessary know-how and industrial capacity to manufacture essential medicines. The recent Decision adopted at the 12th WTO Ministerial Conference provides the opportunity to focus again on the topic and deal with the issue of the clash between IP and the national interests of the least developed countries. Instead of addressing the problem by looking at the well-known flexibilities/inflexibilities of the Agreement, this paper proposes a different methodological approach that builds on the flourishing literature on regulatory governance. To this end, a multi-dimensional regulatory approach is suggested that simultaneously exploits a matrix of normative, market-based and cooperative instruments. While we wait for a more structural normative reform, a similar perspective not only proves to be useful from a theoretical perspective, but could also contribute to shedding a new light on the TRIPS Agreement.","PeriodicalId":487734,"journal":{"name":"GRUR international","volume":" 982","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141823190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The European Research and Bolar Exemptions ‒ Background, Status Quo and a Look at the Agreement on a Unified Patent Court (UPCA) and the EU Commission’s New Draft Directive for the Reform of Pharmaceutical Legislation 欧洲研究和生物技术豁免--背景、现状以及统一专利法院协议（UPCA）和欧盟委员会新的药品立法改革指令草案概览

GRUR international Pub Date : 2024-07-19 DOI: 10.1093/grurint/ikae094

Marco Stief

{"title":"The European Research and Bolar Exemptions ‒ Background, Status Quo and a Look at the Agreement on a Unified Patent Court (UPCA) and the EU Commission’s New Draft Directive for the Reform of Pharmaceutical Legislation","authors":"Marco Stief","doi":"10.1093/grurint/ikae094","DOIUrl":"https://doi.org/10.1093/grurint/ikae094","url":null,"abstract":"\u0000 A patent is a form of state monopoly granted to the owner of an invention. A patent rewards its owner with exclusive rights in exchange for innovation (‘quid pro quo’) for a limited period of time. These exclusive rights allow the patent holder to prohibit others from using the patented invention, helping to recover their research and development (R&D) costs and thereby create an incentive for further innovation. However, patents can hinder technical progress if no restrictions are imposed. Therefore, exceptions and restrictions exist to balance patent protection with the right to freedom of research under Art. 13 of the EU Charter. The most important exceptions are the so-called Bolar and research exemptions. The Bolar exemption allows generics manufacturers to seek authorization or approval under pharmaceutical law before a patent expires, enabling market entry immediately after patent expiration. The research exemption permits the use of patented inventions for research purposes. These two exceptions are increasingly important due to a shift in patent law favoring patent holders through simplified procedures and expanded rights. This article briefly outlines the history and application requirements of these two exemptions and the limits and restrictions to be observed. It also discusses the national differences in application of the Bolar and research exemptions within Europe and the new Art. 27 UPCA introduced in June 2023. Finally, the proposed amendments published in April 2023 as part of the new European pharmaceutical package will be discussed.","PeriodicalId":487734,"journal":{"name":"GRUR international","volume":" September","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141823715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0